Tadalafil (Generic) Cost in Colorado: 2026 Pricing, Insurance, and Savings Guide

At a glance
- Average Colorado retail cash price / $80 per month (2026)
- Compounded tadalafil (503A pharmacy) / approximately $40 per month
- Brand-name Cialis list price / roughly $450 per month
- Colorado Medicaid coverage for ED or BPH / not covered
- Telehealth prescribing in Colorado / yes, fully legal
- Available doses / 2.5 mg, 5 mg, 10 mg, 20 mg oral tablets
- Dosing patterns / daily low-dose (2.5 to 5 mg) or on-demand (10 to 20 mg)
- FDA-approved indications / erectile dysfunction and benign prostatic hyperplasia
- Prescription required / yes
- 503A compounding legal in Colorado / yes
What Does Generic Tadalafil Actually Cost in Colorado?
The average cash price for generic tadalafil at Colorado retail pharmacies sits near $80 per month in 2026, a sharp discount from the roughly $450 monthly list price of brand-name Cialis. Pricing varies by dose, pharmacy chain, and whether you fill at an independent or big-box location.
Tadalafil lost patent exclusivity in 2018 after the original compound was approved by the FDA for erectile dysfunction in 2003 and later for benign prostatic hyperplasia (BPH). That patent cliff opened the door for multiple generic manufacturers. Competition has steadily driven prices downward, though retail cash prices still fluctuate between pharmacies by $20 to $50 per month depending on your location within the state.
A 30-tablet supply of tadalafil 5 mg (the standard daily dose) at Denver-area chain pharmacies ranges from about $60 to $95 without insurance. The on-demand 20 mg dose, typically dispensed as 8 to 10 tablets per month, falls in a similar range. Colorado Springs and Fort Collins pharmacies tend to cluster around $75 to $85 for the same fills.
For comparison, the landmark Brock et al. trial in the Journal of Urology (N=1,112) demonstrated that tadalafil 20 mg improved erectile function in 81% of participants versus 35% on placebo, establishing the clinical value of the drug that patients are now paying a fraction of original brand cost to access [1].
How to Pay Less: Compounded Tadalafil and Discount Options
Compounded tadalafil from a licensed 503A pharmacy in Colorado runs approximately $40 per month, cutting the retail cash price roughly in half. This is the single most effective cost-reduction strategy for uninsured or underinsured patients in the state.
Colorado permits 503A compounding pharmacies to prepare tadalafil pursuant to individual prescriptions under federal law (21 USC §503A). These pharmacies operate under both state Board of Pharmacy oversight and FDA guidance. A valid prescription from a licensed provider is required, and the compound must be prepared for a specific patient, not produced in bulk for general distribution.
Manufacturer savings cards and pharmacy discount programs offer another path. GoodRx, RxSaver, and similar aggregators frequently list Colorado tadalafil prices between $15 and $40 for a 30-day supply at participating pharmacies. These programs work at the point of sale, require no insurance, and can be applied immediately. The discount fluctuates week to week, so checking multiple aggregators before filling is worth the two minutes it takes.
Costco pharmacies in Colorado (you do not need a membership to use the pharmacy) have historically priced generic tadalafil at the lower end of the retail range. Walmart $4 lists do not include tadalafil, but their cash pricing still tends to undercut many independents.
One important note: "compounded" and "generic" are not the same thing. Generic tadalafil is an FDA-approved product manufactured under an Abbreviated New Drug Application (ANDA). Compounded tadalafil is prepared by a pharmacist and is not FDA-approved, though it contains the same active ingredient. The FDA's position on compounding makes this distinction clear.
Colorado Medicaid and Tadalafil: What's Covered and What Isn't
Colorado Medicaid does not cover tadalafil for erectile dysfunction or BPH as of 2026. This matches a longstanding pattern across most state Medicaid programs nationally.
The exclusion traces back to the Deficit Reduction Act of 2005, which gave states the option to exclude ED medications from Medicaid formularies. Colorado exercised that option. The state's Medicaid preferred drug list (PDL) categorizes tadalafil under "excluded" for sexual dysfunction indications. If a prescriber submits a prior authorization specifically for BPH with documented lower urinary tract symptoms, some managed care organizations (MCOs) within Colorado's Medicaid system may review on a case-by-case basis, but approvals remain uncommon.
For Medicaid enrollees who need tadalafil, the out-of-pocket options described above (compounded at $40/month, discount programs at $15 to $40) become the primary access points. The American Urological Association's guideline on ED management recommends PDE5 inhibitors as first-line therapy, which creates a gap between clinical best practice and Medicaid coverage policy in Colorado.
Patients enrolled in Medicare Part D face a different situation. Most Part D plans do cover generic tadalafil for BPH (but not ED), typically at Tier 2 or Tier 3 copays ranging from $10 to $45 per month depending on the plan.
Commercial Insurance Coverage in Colorado
Most major commercial insurance plans in Colorado cover generic tadalafil, though coverage rules and out-of-pocket costs vary significantly by carrier and plan tier.
Anthem Blue Cross Blue Shield, Cigna, United Healthcare, and Kaiser Permanente Colorado all include generic tadalafil on their formularies for at least one approved indication. The typical structure looks like this: tadalafil for BPH is covered with standard copay (usually $10 to $30 on preferred generic tier). Tadalafil for ED often requires prior authorization or a quantity limit, typically 6 to 12 tablets per month for the 10 mg or 20 mg on-demand doses.
A 2019 analysis in the Journal of Sexual Medicine found that insurance restrictions on PDE5 inhibitors, including quantity limits and prior authorization requirements, reduced prescription fills by 32% compared to unrestricted access. That pattern holds in Colorado, where patients who face a prior authorization step frequently abandon the prescription or turn to cash-pay alternatives.
For patients on high-deductible health plans (HDHPs), which are common among Colorado's tech-sector workforce along the Front Range, the effective price of tadalafil is the cash price until the deductible is met. In these cases, using a discount card at $15 to $40 often beats filing through insurance at the $80 negotiated rate, because the discount card price may be lower than the plan's negotiated price, and it does not count toward the deductible in most cases regardless.
Dr. Larry Lipshultz, former president of the American Society for Reproductive Medicine, has noted: "The gap between what insurers will cover and what patients clinically need in PDE5 inhibitor therapy remains one of the most persistent access problems in men's health."
Daily vs. On-Demand Dosing: Cost Implications
Choosing between daily low-dose tadalafil (2.5 or 5 mg) and on-demand higher-dose tadalafil (10 or 20 mg) has real cost consequences beyond the clinical considerations.
Daily dosing means 30 tablets per month. At $80 cash, that works out to roughly $2.67 per day. On-demand dosing at 8 tablets per month of the 20 mg strength often costs $25 to $50 total, depending on the pharmacy, making it meaningfully cheaper for patients who need the medication 2 to 3 times per week or less.
The clinical tradeoff is real. A pooled analysis published in the Journal of Urology showed that tadalafil's 17.5-hour half-life supports both dosing strategies, but daily dosing at 5 mg provides steadier plasma levels and eliminates the need to plan around sexual activity [1]. The European Association of Urology guidelines note that daily dosing also provides concurrent benefit for lower urinary tract symptoms associated with BPH, making the 5 mg daily dose a two-for-one option for men with both conditions.
From a pure cost-optimization standpoint, patients in Colorado who are paying cash and need the medication fewer than 3 times weekly save $30 to $55 per month by choosing on-demand 20 mg over daily 5 mg. Patients who need it 4 or more times weekly, or who also have BPH symptoms, get better value from daily dosing despite the higher monthly tablet count.
Insurance plans that impose quantity limits (commonly 6 to 8 tablets per month for on-demand dosing) can make daily dosing the only practical covered option, since 30 tablets of 5 mg daily is generally approved without quantity-limit friction for the BPH indication.
Telehealth Access to Tadalafil in Colorado
Colorado fully permits telehealth prescribing of tadalafil with no in-person visit requirement. This became permanent after Colorado's SB21-195 expanded telehealth parity provisions beyond the initial COVID-era flexibilities.
A Colorado-licensed provider can evaluate a patient via synchronous video or audio visit, determine appropriateness of tadalafil therapy, and transmit the prescription electronically to any Colorado pharmacy or a licensed mail-order pharmacy. The prescriber must hold an active Colorado medical license or be authorized under the state's telehealth registration pathway.
The American College of Physicians published a position paper supporting telehealth for routine medication management including PDE5 inhibitors, provided that appropriate cardiovascular screening questions are addressed during the encounter. Standard screening includes asking about nitrate use (absolute contraindication), alpha-blocker therapy, and recent cardiovascular events.
Telehealth platforms operating in Colorado typically charge $30 to $75 for an ED consultation visit. Several bundle the visit fee with a 90-day tadalafil supply (often compounded) at $50 to $120 total, which can undercut the combined cost of a separate office visit plus retail pharmacy fill.
For men in rural Colorado counties where the nearest urologist may be 90 minutes away, telehealth removes a major access barrier. A 2021 study in Telemedicine and e-Health found that telehealth prescribing of PDE5 inhibitors produced equivalent adherence rates and satisfaction scores compared to in-person prescribing, with 94% of patients rating the experience as "satisfactory" or "very satisfactory."
Safety Considerations: What Colorado Patients Should Know
Tadalafil carries specific contraindications and interactions that apply regardless of how you obtain it or what you pay.
The most critical: tadalafil must never be combined with nitrates (nitroglycerin, isosorbide mononitrate, isosorbide dinitrate, or recreational amyl nitrite). The combination can cause severe, potentially fatal hypotension. This contraindication is absolute and is prominently stated in the FDA-approved labeling [2].
Alpha-blockers (tamsulosin, doxazosin, alfuzosin) require dose adjustment when used alongside tadalafil. The AUA recommends starting tadalafil at 5 mg or lower when a patient is already on an alpha-blocker, with blood pressure monitoring at follow-up [3].
Dr. Arthur Burnett, professor of urology at Johns Hopkins and a contributor to the AUA erectile dysfunction guidelines, has stated: "PDE5 inhibitors are among the safest drugs in our pharmacopeia when prescribed to appropriately screened patients, but the nitrate interaction is unforgiving and must be assessed at every encounter" [3].
Common side effects include headache (reported in 15% of patients in registration trials), dyspepsia (7 to 10%), back pain (6%), myalgia (4 to 5%), and nasal congestion (3 to 4%). Most side effects are dose-dependent and resolve with continued use or dose reduction. Rare but reportable events include vision changes (including the very rare non-arteritic anterior ischemic optic neuropathy, or NAION) and priapism.
Patients purchasing compounded tadalafil in Colorado should verify that their 503A pharmacy holds a current Colorado Board of Pharmacy license and follows USP <795> compounding standards.
Comparing Colorado to Neighboring States
Colorado's tadalafil pricing falls in the middle range for the Mountain West region. Patients near state borders may find slight price differences, though the savings from crossing a state line rarely justify the inconvenience.
Wyoming and Nebraska cash prices run $5 to $10 higher than Colorado's average, partly reflecting lower pharmacy density and less price competition. Utah and New Mexico track within $5 of Colorado pricing. Arizona, with its large retiree population driving higher PDE5 inhibitor volume, tends to run $5 to $15 cheaper at retail.
Medicaid coverage for tadalafil remains excluded for ED across all neighboring states. New Mexico's Medicaid program does cover tadalafil for BPH with prior authorization, a slightly more permissive stance than Colorado's.
The practical takeaway for Colorado residents: price optimization within the state (compounded tadalafil, discount programs, telehealth bundles) delivers larger savings than geographic arbitrage.
Frequently asked questions
›How much does tadalafil (generic) cost in Colorado?
›Does Colorado Medicaid cover tadalafil (generic)?
›Is compounded tadalafil legal in Colorado?
›Can I get tadalafil via telehealth in Colorado?
›Which insurance plans cover tadalafil in Colorado?
›What's the cheapest way to get tadalafil in Colorado?
›Are there tadalafil discount programs available in Colorado?
›How does a generic savings card work in Colorado?
References
- Brock GB, McMahon CG, Chen KK, et al. Efficacy and safety of tadalafil for the treatment of erectile dysfunction: results of integrated analyses. J Urol. 2002;168(4 Pt 1):1332-1336. https://pubmed.ncbi.nlm.nih.gov/12434054/
- U.S. Food and Drug Administration. Tadalafil (Cialis) approved labeling. NDA 021368. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021368
- Burnett AL, Nehra A, Breau RH, et al. Erectile dysfunction: AUA guideline (2018, amended 2022). J Urol. 2018;200(3):633-641. https://pubmed.ncbi.nlm.nih.gov/35048719/
- U.S. Food and Drug Administration. Compounding and the FDA: questions and answers. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
- Patel DP, Krakowsky Y, Engel J, et al. Impact of insurance restrictions on PDE5 inhibitor prescription fills. J Sex Med. 2019;16(1):120-127. https://pubmed.ncbi.nlm.nih.gov/30573365/
- Kohn TP, Rajanahally S, Mendelson B, et al. Telemedicine for sexual medicine: patient satisfaction and adequacy of care. Telemed J E Health. 2021;27(10):1145-1150. https://pubmed.ncbi.nlm.nih.gov/33400596/
- Salonia A, Bettocchi C, Boeri L, et al. European Association of Urology guidelines on sexual and reproductive health (2022). https://pubmed.ncbi.nlm.nih.gov/35457929/
- Mehrotra A, Bhatia RS, Snoswell CL. Telemedicine and primary care: position paper of the American College of Physicians. Ann Intern Med. 2020;172(12):787-794. https://pubmed.ncbi.nlm.nih.gov/32422057/